Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Photofrin enters phase III testing for new indication

Jan. 14, 1998

New anticancer combination associated with high efficacy in phase II metastatic breast cancer trial

Jan. 13, 1998

Analog II: a novel antiestrogen with selective activity against breast cancer

Jan. 13, 1998

Temodal submitted for approval in E.U.

Jan. 13, 1998

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Jan. 13, 1998

Chemogene therapy: a new therapeutic approach on the horizon?

Jan. 13, 1998

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Jan. 12, 1998

FDA approves Photofrin for early-stage lung cancer

Jan. 12, 1998

New mycotoxin with antitumor and favorable hematological effects

Jan. 12, 1998

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...